Valuation: Lifestyle Delivery Systems Inc

Market Cap 10.2M 7.38M 6.33M 5.91M 5.42M 705M 10.37M 69.75M 27.31M 354M 27.71M 27.11M 1.17B P/E 2022 *
-
P/E 2023 -0.92x
Enterprise Value 9.74M 7.05M 6.05M 5.65M 5.18M 674M 9.9M 66.62M 26.09M 338M 26.47M 25.89M 1.12B EV / Sales 2022 *
-
EV / Sales 2023 43x
Free-Float
99.7%
Yield 2022 *
-
Yield 2023 -
Change 5-day change 1-year change 3-year change Capi.($)
-10.84%-40.80% - - 47
+0.92%-0.67%-11.18%-4.69% 13.19B
-0.46%-3.30%-34.03%-57.25% 4.9B
-0.27%-2.59%+1.82%-0.14% 4.91B
+5.27%+3.58%+6.89%-24.07% 4.1B
-0.59%-2.91%-25.50%+3.09% 3.53B
-0.97%-0.46%-12.31%+14.41% 3.38B
+3.46%-1.39%-6.55%-5.34% 3.4B
-1.46%-1.95%-17.15%-17.10% 2.44B
-5.02%-8.42%-6.05%-14.87% 1.64B
Average -1.00%-1.74%-11.56%-11.77% 4.61B
Weighted average by Cap. +0.60%-0.94%-11.64%-11.24%

Financials

2021 2022 *
Net sales 432K 312K 268K 250K 230K 29.85M 439K 2.95M 1.16M 14.97M 1.17M 1.15M 49.5M -
Net income -37.05M -26.81M -23M -21.48M -19.7M -2.56B -37.66M -253M -99.24M -1.29B -101M -98.49M -4.25B -
Net Debt -843K -610K -523K -489K -448K -58.33M -857K -5.77M -2.26M -29.25M -2.29M -2.24M -96.72M -
Logo Lifestyle Delivery Systems Inc
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Employees
-